Bausch Health Companies Inc. (BHC) — Analyst outlook / Analyst consensus target is. Based on 38 analyst ratings, the consensus is bullish — 19 Buy, 15 Hold, 4 Sell.
The consensus price target is $8.00, representing an upside of 40.8% from the current price $5.68.
Analysts estimate Earnings Per Share (EPS) of $3.75 and revenue of $9.59B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.13 vs est $3.75 (missed -103.5%). 2025: actual $0.41 vs est $3.87 (missed -89.4%). Analyst accuracy: 0%.
BHC Stock — 12-Month Price Forecast
$8.00
▲ +40.85% Upside
Average Price Target
Based on 38 Wall Street analysts offering 12-month price targets for Bausch Health Companies Inc., the price target is $8.00.
The average price target represents a +40.85% change from the last price of $5.68.
BHC Analyst Ratings
Buy
Based on 38 analysts giving stock ratings to Bausch Health Companies Inc. in the past 3 months
EPS Estimates — BHC
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.13
vs Est $3.75
▼ 2,981.2% off
2025
Actual $0.41
vs Est $3.87
▼ 844.8% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — BHC
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $9.518B
vs Est $9.588B
▼ 0.7% off
2025
Actual $10.309B
vs Est $10.251B
▲ 0.6% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
